Logotype for Temenos AG

Temenos (TEMN) Q2 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Temenos AG

Q2 2024 earnings summary

8 Jul, 2026

Executive summary

  • Q2 2024 saw all delayed Q1 deals close, strong customer engagement at the Temenos Community Forum, and 101 customer go-lives, up from 62 in Q1.

  • The Temenos SaaS Foundation, a next-gen SaaS platform, was launched and already has a tier-one European bank live.

  • Senior leadership strengthened with a new CEO, CRO, President Americas, CMO, and EVP of Global Alliances, with go-to-market investments in the US and Western Europe.

  • Two-month sales delays from a short seller report impacted H1, leading to revised FY-24 guidance.

  • Strategic and financial plan to be presented at Capital Markets Day in November 2024.

Financial highlights

  • Q2-24 ARR reached USD 742.4m, up 12% year-over-year at constant currency, with sequential growth resuming after a Q1 dip.

  • Total revenue grew 5% year-over-year; non-IFRS EBIT rose 7% to USD 90.4m, with margin expanding to 37.4%.

  • Free cash flow was USD 73m, up 16% year-over-year, with cash conversion at 121% of IFRS EBITDA.

  • EPS (non-IFRS) up 8% year-over-year; IFRS EPS was USD 0.50 (down 6%).

  • SaaS revenue grew 8% year-over-year; maintenance revenue up 11% year-over-year.

Outlook and guidance

  • Revised FY-24 guidance: ARR growth about 13% (was 15%), total software licensing growth 3-6% (was 7-10%), EBIT growth 7-9%, EPS growth 6-8%, and free cash flow growth at least 16%.

  • Guidance assumes return to growth and de-risking for H2-24, with Q3 expected to be better than Q2 for total software licensing.

  • FY-24 tax rate expected between 20-22%, with assumed FX rates: EUR/USD 1.08, GBP/USD 1.26, USD/CHF 0.89.

  • Midterm targets to be revisited at the November Capital Markets Day.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more